About Invivyd, Inc. 
Invivyd, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 18 Schemes (11.96%)
Foreign Institutions
Held by 33 Foreign Institutions (1.8%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
12 Million
(Quarterly Results - Jun 2025)
Net Profit:
-15 Million
Pharmaceuticals & Biotechnology
USD 226 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.79
-257.38%
5.29






